The Rise Of Growing Snakebite Incidents Drive Expansion Of The Is Influencing The Animal Model Market

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Animal Model Market Compare Between 2026 And 2030?

The animal model market has observed substantial growth in recent years. This market is projected to expand from $2.07 billion in 2025 to $2.24 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.5%. The historical growth of this market stems from factors such as the increasing prevalence of chronic diseases, a heightened demand for preclinical research, advancements in pharmaceutical R&D, technological progress in laboratory equipment, and the expansion of academic research institutions.

The animal model market size is projected to witness robust expansion in the upcoming years, with an estimated valuation of $2.97 billion by 2030, achieving a compound annual growth rate (CAGR) of 7.3%. This growth during the forecast period is largely attributable to the integration of AI and machine learning in preclinical investigations, the emergence of precision medicine initiatives, the escalating influence of CROs and outsourcing activities, the wider availability of genetically modified animal models, and a heightened commitment to translational research. Significant trends anticipated for this period include the evolution of advanced animal models, the development of genetically engineered models, the application of high-throughput screening in preclinical studies, the incorporation of imaging and diagnostic technologies, and the continued expansion of contract research organizations.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15510&type=smp

What Primary Drivers Are Shaping The Animal Model Market?

Increased investment in pharmaceutical research and development (R&D) is projected to drive expansion within the animal model market in the future. This R&D encompasses the discovery, development, and testing of novel treatments, necessitating comprehensive preclinical studies to assess their safety, effectiveness, and underlying biological mechanisms prior to progression into human trials. The surge in R&D expenditure stems from an escalating demand for pioneering therapies, the rising incidence of intricate diseases, and ongoing scientific progress. Within this context, animal models are crucial, offering dependable preclinical platforms that simulate human physiology and permit the predictive evaluation of drug performance. As an illustration, a report released in November 2023 by the European Federation of Pharmaceutical Industries and Associations, a trade association based in Belgium, indicated that pharmaceutical industry research and development spending climbed to 50,000 million in 2023, an increase from 47,010 million in 2022. Consequently, the upward trend in pharmaceutical R&D expenditure is fueling the expansion of the animal model market.

What Are The Different Segment Types In The Animal Model Market Segment Breakdown?

The animal model market covered in this report is segmented –

1) By Animal Type: Mice, Rat, Guinea Pigs, Rabbits, Hamsters, Other Animal Types

2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies

3) By Application: Drug Discovery And Development, Basic Research, Other Applications

4) By End User: Research Institutes, Educational Institutes, Pharmaceutical Companies, Contract Research Organizations

Subsegments:

1) By Mice: Inbred Mice, Outbred Mice, Knockout Mice, Transgenic Mice

2) By Rat: Inbred Rats, Outbred Rats, Transgenic Rats, Knockout Rats

3) By Guinea Pigs: Standard Guinea Pigs, Immunodeficient Guinea Pigs

4) By Rabbits: New Zealand White Rabbits, Dutch Belted Rabbits, Other Rabbit Breeds

5) By Hamsters: Syrian Hamsters, Chinese Hamsters

6) By Other Animal Types: Non-Human Primates (Monkeys, Chimpanzees), Dogs, Pigs, Sheep, Ferrets, Other Small Animals (Ferrets, Gerbils)

What Trends Are Shaping The Future Of The Animal Model Market?

Leading companies in the animal model sector are dedicating efforts to developing cutting-edge products, such as triple-immunodeficient animal models, aiming to boost the accuracy and reliability of preclinical investigations, support advanced biomedical research, and accelerate the development of new therapies for complex human conditions. These triple-immunodeficient animal models are specifically engineered creatures, usually mice, designed to be missing three essential components of the immune system. Such models are incredibly valuable in biomedical research, especially for investigating human diseases and devising novel treatments. As an example, in January 2024, Charles River Laboratories International, Inc., a pharmaceutical company from the US, introduced NCG mouse strains, which represent a triple-immunodeficient mouse model specifically for oncology research. NCG mice are characterized by their triple immunodeficiency, meaning they lack functional or mature T, B, and NK cells, and also show diminished macrophage and dendritic cell functionality. These particular animal models are capable of hosting xenograft cells, tissues, and components of the human immune system. This mouse model proves ideal for studies in areas such as oncology, immunology, tumor biology, infectious diseases, graft-versus-host disease (GvHD), diabetes, regenerative medicine, hematopoiesis, and tissue transplant research. Furthermore, NCG mice can be used to generate humanized mice by engrafting PBMCs or CD34+ stem cells, thereby providing a close imitation of the human immune system.

Who Are The Well-Known Companies In The Animal Model Market?

Major companies operating in the animal model market are Eurofins Scientific SE, Charles River Laboratories International Inc., Pharmaron Beijing Co Ltd, Inotiv Inc., Biocytogen, Taconic Biosciences Incorporation, Cyagen Biosciences, Trans Genic Incorporation, Crown Bioscience Incorporation, Harbor BioMed, PharmaLegacy, PsychoGenics, Biomere Biomedical Research Models Inc., Genoway S.A, Alloy Therapeutics, Janvier Labs, Hera Biolabs, Ozgene Pty Ltd, Transposagen Biopharmaceuticals Inc., KMT Hepatech Inc., AniLocus Inc., BioXpert, Harlan Sprague Dawley Inc.

Get The Full Animal Model Market Report:

https://www.thebusinessresearchcompany.com/report/animal-model-global-market-report

Which Region Is The Top Contributor To The Animal Model Market By Share?

North America was the largest region in the animal model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Animal Model Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/animal-model-global-market-report

Browse Through More Reports Similar to the Global Animal Model Market 2026, By The Business Research Company

Animal Model Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-model-global-market-report

Rat Model Market Report 2026

https://www.thebusinessresearchcompany.com/report/rat-model-global-market-report

Anatomical Models Market Report 2026

https://www.thebusinessresearchcompany.com/report/anatomical-models-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795